| Financial Year |
March 31 2023 |
| Monetary Funds |
1,174,938,002.30 |
| Held-for-trading Financial Assets |
214,668,801.93 |
| Notes Receivable |
290,432,195.28 |
| Accounts Receivable |
1,684,145,191.37 |
| Advances to Suppliers |
27,976,270.72 |
| Other Receivables |
15,051,640.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
627,920,682.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
254,904,941.56 |
| Other Current Assets |
261,436,520.45 |
| Total Current Assets |
4,680,211,129.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
305,646,206.58 |
| Investment Properties |
151,215,161.90 |
| Fixed Assetes |
2,709,709,180.85 |
| Under-construction Projects |
2,014,815,994.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,080,193.11 |
| R&D expenses |
-- |
| Goodwill |
274,521,767.79 |
| Long-Term Deferred and Prepaid Expenses |
86,766,412.60 |
| Deferred Income Tax Assets |
156,170,863.05 |
| Other Non-Current Assets |
876,814,171.47 |
| Sub-Total of Non-Current Assets |
7,399,740,042.13 |
| Total Assets |
12,079,951,171.93 |
| Short-Term Loans |
618,131,909.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
276,054,852.34 |
| Accounts Payable |
1,282,984,607.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
122,452,840.57 |
| Taxes Payable |
121,391,211.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,574,876.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
465,709,289.55 |
| Other Current Liabilities |
7,580,725.67 |
| Sub-Total of Current Liabilities |
2,968,677,192.33 |
| Long-term Loans |
1,631,865,233.96 |
| Bonds Payable |
251,795,857.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
126,719,097.32 |
| Other Non-Current Liabilities |
3,289,376.26 |
| Sub-Total of Non-Current Liabilities |
2,049,021,690.39 |
| Total Liabilities |
5,017,698,882.72 |
| Paid-In Capital(Or Share Stock) |
1,689,546,403.00 |
| Capital Surplus |
1,937,824,991.49 |
| Surplus Reserve |
63,642,804.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,399,266,879.22 |
| Minority Stockholder's Interest |
480,819,314.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,581,432,974.74 |
| Owner's Equity（Stockholder's Equity） |
7,062,252,289.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,079,951,171.93 |
